Paraneoplastic pemphigus occuring after radiotherapy for relapsed non-Hodgkin's lymphoma in a patient with common variable immunodeficiency

Hematology Journal

Volumn 4, Issue 2, 2003, Pages 154-158

  Stark, G L ^a   Goff, D K ^a   Spickett, G P ^b   Wojnarowska, F ^c   Langtry, J A A ^a  

^a SUNDERLAND ROYAL HOSPITAL   (United Kingdom)

^b ROYAL VICTORIA INFIRMARY   (United Kingdom)

^c CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

Chronic lymphocytic leukemia; Common variable immunodeficiency; Non Hodgkin's lymphoma; Oral ulceration; Paraneoplastic pemphigus

Indexed keywords

ANTIBIOTIC AGENT; AUTOANTIBODY; AZATHIOPRINE; CHLORAMBUCIL; CORTICOSTEROID DERIVATIVE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; IMMUNOGLOBULIN; INFUSION FLUID; METHYLPREDNISOLONE; MONOCLONAL ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; PROCARBAZINE; RITUXIMAB; VINBLASTINE;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; BONE MARROW BIOPSY; BULLOUS SKIN DISEASE; CANCER RECURRENCE; CASE REPORT; CLINICAL FEATURE; COMMON VARIABLE IMMUNODEFICIENCY; COMPUTER ASSISTED TOMOGRAPHY; DISEASE CONTROL; DRUG MEGADOSE; FEMALE; HUMAN; IMMUNOFLUORESCENCE TEST; MOUTH ULCER; MUCOSA INFLAMMATION; NONHODGKIN LYMPHOMA; PARANEOPLASTIC SYNDROME; PEMPHIGUS; PSEUDOMONAS AERUGINOSA; RESPIRATORY FAILURE; SEPTIC SHOCK; SEPTICEMIA; SKIN BIOPSY;

COMMON VARIABLE IMMUNODEFICIENCY; FATAL OUTCOME; FEMALE; HUMANS; LYMPHOMA, NON-HODGKIN; MIDDLE AGED; PARANEOPLASTIC SYNDROMES; PEMPHIGUS; RADIOTHERAPY, ADJUVANT; RESPIRATORY INSUFFICIENCY;

EID: 0037662914     PISSN: 14664860     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.thj.6200221     Document Type: Article

References (20)

1. Anhalt GJ, Kim SC, Stanley JR, Korman NJ, Jabs DA, Kory M et al. Paraneoplastic pemphigus: an auto immune mucocutaneous disease associated with neoplasia. N Engl J Med 1990; 323: 1729-1735.
2. Osmanski JP, Fraire AE, Schaefer OP. Necrotizing tracheobronchitis with progressive air flow obstruction associated with paraneoplastic pemphigus. Chest 1997; 112: 1704-1707.
3. Joly P, Richard C, Gilbert D, Courville P, Chosidow O, Beylot-Barry M et al. Sensitivity and specificity of clinical, histologic and immunologic features in the diagnosis of paraneoplastic pemphigus. J Am Acad Dermatol 2000; 43: 619-626.
4. Nguyen VT, Ndoye A, Bassler KD, Schulz LD, Shields MC, Ruben BS et al. Classification, clinical manifestations and immunopathological mechanisms of the epithelial variant of paraneoplastic autoimmune multiorgan syndrome. Arch Dermatol 2001; 137: 193-206.
5. Nousari HC, Deterding R, Wojtczack H, Aho S, Uitto J, Hashimoto T et al. The mechanism of respiratory failure in paraneoplastic pemphigus. N Engl J Med 1999; 340: 1406-1410.
6. Spickett GP, Farrant J, North ME, Zhang J, Morgan L, Webster ABD. Common variable immunodeficiency: how many diseases? Immunol Today 1991; 18: 325-328.
7. Spickett GP, Zhang JG, Green T, Shrimankar J. Granulomatous disease in common variable immunodeficiency: effect on immunoglobulin replacement therapy and response to steroids and splenectomy. J Clin Pathol 1996; 49: 431-434.
8. McElwain TJ, Toy J, Smith E, Peckham MJ, Austin DE. Combination chemotherapy of chlorambucil, vinblastine, procarbazine and prednisolone for treatment of Hodgkin's disease. Br J Cancer 1977; 36: 276-280.
9. Camsia C, Helm TN. Paraneoplastic pemphigus is a distinct neoplasia-induced autoimmune disease. Arch Dermatol 1993; 129: 883-886.
10. Hermaszewski RA, Webster AD. Primary hypogammaglobulinaemia: a survey of clinical manifestations and complications. Q J Med 1993; 86: 31-42.
11. Cunningham-Rundles C, Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol 1999; 92: 34-48.
12. Fried R, Lynfield Y, Vitale P, Anhalt G. Paraneoplastic pemphigus appearing as a bullous pemphigoid-like eruption after palliative radiation therapy. J Am Acad Dermatol 1993; 29: 915-917.
13. Dega H, Laporte JL, Joly P, Gabarre J, Andre C, Delpech A et al. Paraneoplastic pemphigus associated with Hodgkin's disease. Br J Dermatol 1998; 138: 188-203.
14. Anhalt GJ. Paraneoplastic pemphigus. Adv Dermatol 1997; 12: 77-96.
15. Bowen GM, Peters NT, Fivenson DP, Su LD, Nousari HC, Anhalt GJ et al. Lichenoid dermatitis in paraneoplastic pemphigus. A pathogenic trigger of epitope spreading? Arch Dermatol 2000; 136: 652-656.
16. William JV, Marks Jr JG, Billingsley EM. Use of mycophenolate mofetil in the treatment of paraneoplastic pemphigus. Br J Dermatol 2000; 142: 506-508.
17. Herzberg, MS, Schifter M, Sullivan J, Stapleton K. Paraneoplastic pemphigus in two patients with B-cell non-Hodgkin's lymphoma: significant responses to cyclophosphamide and prednisolone. Am J Hematol 2000; 63: 105-106.
18. Nousari HC, Brodsky RA, Jones RJ, Grever MR, Anhalt GJ. Immunoablative high-dose cyclophosphamide without stem cell rescue in paraneoplastic pemphigus: report of a case and review of this new therapy for severe autoimmune disease. J Am Acad Dermatol 1999; 40: 750-154.
19. Borradori L, Lombardi T, Samson J, Girardet C, Saurat J, Hügli A. Anti-CD20 monoclonal antibody (rituximab) for refractory erosive stomatitis secondary to CD20 + follicufollicular lymphoma-associated paraneoplastic pemphigus. Arch Dermatol 2001; 137: 269-272.
20. Heizmann M, Itin P, Wernli M, Borradori L, Bargetzi MJ. Successful treatment of paraneoplastic pemphigus in follicular NHL with rituximab: report of a case and review of treatment for paraneoplastic pemphigus in NHL and CLL. Am J Hematol 2001; 66: 142-144.